Identification of a novel prognostic signature related to PANoptosis and its regulatory mechanism as well as targeted treatment of active ingredients and traditional Chinese medicine in lung adenocarcinoma

• Main Authors: Shaohui Wang (Author), Ya Hou (Author), Nan Xing (Author), Xianli Meng (Author), Yi Zhang (Author), Xiaobo Wang (Author)
• Format: Book
• Published: Elsevier, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lung adenocarcinoma (LUAD) with a poor prognosis is the most common type of lung cancer, and one of the most aggressive and rapidly fatal tumor types. PANoptosis is a newly identified pro-inflammatory programmed cell death pathway controlled by the recently discovered cytoplasmic polymeric protein c...